Dow Down 0.08% Nasdaq Down 0.35%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
1.61 Down 0.13(7.47%) Feb 9, 4:00PM EST
Prev Close:1.74
Open:1.73
Bid:1.25 x 200
Ask:4.94 x 1000
1y Target Est:5.25
Beta:2.67005
Earnings Date:Feb 23 - Feb 29 (Est.)
Day's Range:1.57 - 1.73
52wk Range:1.39 - 9.37
Volume:1,436,961
Avg Vol (3m):2,420,540
Market Cap:234.16M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 7.47%234.16M
GSKDown 0.33%95.20B
ABTDown 1.23%55.19B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.50
Quarterly EPS Est (Dec-15) :-0.08
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback